Editor-in-Chief

Ronald W. Ellis

Senior Vice President R&D and Chief Technology Officer
NasVax Ltd.
Ness Ziona, IL
Email

Associate Editors

Martin Bachmann

Cytos Biotechnologies
Schlieren, CH
Email

David Baxter

Department of Translational Medicine
University of Manchester Medical School
Manchester, UK
Email

Sujit Kumar Bhattacharya

National Institute of Cholera and Enteric Diseases
Kolkata, IN
Email

Joel Bozue

United States Army Medical Research Institute of Infectious Diseases
Fort Detrick, MD, US
Email

David Cribbs

University of California, Irvine School of Medicine
Irvine, CA, US

Adil Daud

University of California at San Francisco
San Francisco, CA, US
Email

Robert S. Daum

University of Chicago
Chicago, IL, US
Email

Heather Davis

Pfizer Vaccines
Kanata, ON, CA
Email

Robert Edelman

University of Maryland School of Medicine
Baltimore, MD, US
Email

Susanna Esposito

University of Milan, IRCCS Policlinico
Milano, IT

Jean-Louis Excler

International AIDS Vaccine Initiative
Trelex, CH
Email

Ian Feavers

National Institute for Biological Standards and Control
Potters Bar, UK
Email

Ricardo Galler

Instituto de Tecnologia em Imunobiologicos, Biomanguinhos
Rio de Janeiro, BR
Email

Nathalie Garçon

GlaxoSmithKline Biologicals
Rixensart, BE

Vladimir Gilca

Institut national de santé publique du Québec, Laval University, Québec, Canada
Email

Gregory Glenn

Novavax Inc.
Rockville, MD, US
Email

Andrew Gorringe

Health Protection Agency Centre for Emergency Preparedness and Response
Salisbury, UK
Email

Carlos A. Guzman

Helmholtz Centre for Infection Research
Braunschweig, DE
Email

Diane Harper

University of Missouri - Kansas City
Kansas City, MO, US
Email

Leonard C. Harrison

Walter & Eliza Hall Institute of Medical Research
Parkville, Vic, AU
Email

Geneviève Inchauspé

Transgene
Lyon, FR
Email

Mark A. Kane

Consultant
Mercer Island, WA, US
Email

Kevin Killeen

Matrivax Research & Development Corp
Boston, MA, US
Email

Hiroshi Kiyono

The University of Tokyo- Institute of Medical Science
Tokyo, JP
Email

Nils Lycke

University of Goteborg
Goteborg, SE
Email

C. Russell Middaugh

University of Kansas
Lawrence, KS, US

Philippe Moingeon

Stallergenes
Antony, FR
Email

Mark J. Newman

Consultant
Smyrna, GA, US
Email

Charles Nicolette

Argos Therapeutics
Durham, NC, US
Email

Miguel O'Ryan

University of Chile
Santiago, CL
Email

Michael E. Pichichero

Rochester General Hospital Research Institute
Rochester, NY, US
Email

Gerald Pier

Harvard Medical School
Boston, MA, US
Email

Michael W. Russell

University of New York at Buffalo
Buffalo, NY, US
Email

John Schiller

National Cancer Institute
Bethesda, MD, US
Email

Tom Shimabukuro

Centers for Disease Control and Prevention
Atlanta, Georgia, US
Email

Jo Southern

Health Protection Agency
London, UK
Email

Daniel Speiser

Ludwig Institute for Cancer Research
Lausanne, CH
Email

Larry Steinman

Stanford University
Palo Alto, CA, US
Email

James Tartaglia

Sanofi Pasteur
Swiftwater, PA, US
Email

Jeffery Ulmer

Novartis Vaccines
Cambridge, MA, US
Email

Matthias von Herrath

La Jolla Institute for Allergy and Immunology
San Diego, CA, US
Email

Brian J. Ward

McGill University
Montreal, QC, CA
Email

Michael Watson

Sanofi Pasteur
Lyons, FR
Email

Bruce G. Weniger

Research Institute for Health Sciences; Chiang Mai University
Atlanta, GA, US
Email

Editorial Board

Sudhir Agrawal

Idera Pharmaceuticals Inc.
Cambridge, MA, US
Email

Ruth Arnon

Weizmann Institute of Science
Rehevot, IL
Email

Steven Black

Kaiser Permanente
Oakland, CA, US
Email

Robert T. Chen

Centers for Disease Control and Prevention
Atlanta, GA, US
Email

Ron Dagan

Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
Email

Angus G. Dalgleish

St. George's Hospital Medical School
London, UK
Email

Anne S. De Groot

EpiVax Inc
Providence, RI, US
Email

Gordon Douglas

Consultant
Niantic, CT, US
Email

Kathryn Edwards

Vanderbilt University
Nashville, TN, US
Email

Jose Ezparza

Bill & Melinda Gates Foundation
Seattle, WA, US
Email

Ian H. Frazer

University of Queensland
Brisbane, Qld, AU
Email

Jaap Goudsmit

Crucell
Amsterdam, NL
Email

Dan Granoff

Children’s Hospital Oakland Research Institute
Oakland, CA, US
Email

Brian Greenwood

London School of Hygiene & Tropical Medicine
London, UK
Email

Marion Gruber

Food and Drug Administration
Rockland, MD, US
Email

Ian Gust

University of Melbourne
Melbourne, Vic, AU
Email

Scott Halperin

Dalhousie University
Halifax, NS, CA
Email

Michael G. Hanna

Vaccinogen
Frederick, MA, US
Email

Karl Hellstrom

Harborview Medical Center
Seattle, WA, US
Email

David C. Kaslow

Merck Research Laboratories
West Point, PA, US
Email

Myron M. Levine

University of Maryland School of Medicine
Baltimore, MD, US
Email

Alf Lindberg

Nobel Foundation
Stockholm, SE
Email

Thomas P. Monath

Kleiner Perkins Caufield & Byers
Harvard, MA, US
Email

Paul A. Offit

Children's Hospital of Philadelphia
Philadelphia, PA, US
Email

Stanley A. Plotkin

University of Pennsylvania
Philadelphia, PA, US
Email

Regina Rabinovich

Bill & Melinda Gates Foundation
Seattle, WA, US
Email

Philip Russell

Albert Sabin Vaccine Institute
Washington, DC, US
Email

David Salisbury

UK Department of Health
London, UK
Email

Yiming Shao

Chinese Center for Disease Control and Prevention
Beijing, CN
Email

Bing Sun

Chinese Academy of Sciences
Shanghai, CN
Email

John J. Treanor

University of Rochester
Rochester, NY, US
Email

Alexander von Gabain

Intercell
Vienna, AT
Email

David B. Weiner

University of Pennsylvania
Philadelphia, PA, US
Email

Howard L. Weiner

Harvard Medical School, Childrens Hospital
Boston, MA, US
Email